CD4 and lymphoma: showed that CD4+ T cell cytotoxicity played a critical role in delivering anti-tumor effects of anti-PD1 antibody which was observed in MHC-I−MHC-II+ tumors, but not on MHC-I−MHC-II− tumors, in murine models of lymphoma and solid tumors (190).